2008
DOI: 10.2741/3020
|View full text |Cite
|
Sign up to set email alerts
|

Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo

Abstract: Gel-like carrier materials were introduced into cell therapy of cartilage lesions to improve chondrocyte retention and distribution in the defect. Mesenchymal stem cells (MSC) are now discussed as an alternative cell source for repair. We here asked whether distinct gel-like carriers can support chondrogenesis of MSC in vitro and lead to stable cartilage-like transplants in vivo. Chondrogenesis of MSC embedded in collagen type I gel, fibrin glue, Matrigel and PuraMatrix peptide hydrogel was assessed and gene e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
68
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(70 citation statements)
references
References 37 publications
2
68
0
Order By: Relevance
“…In agreement with what has been observed previously (Dickhut et al, 2008;Scotti et al, 2013;Sheehy et al, 2013;Vinardell et al, 2012), cartilage tissues engineered using BMSCs appeared to proceed down the endochondral pathway in vivo, with increased type X collagen expression and mineralisation of the engineered tissue. This occurred for both agarose encapsulation and SA.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…In agreement with what has been observed previously (Dickhut et al, 2008;Scotti et al, 2013;Sheehy et al, 2013;Vinardell et al, 2012), cartilage tissues engineered using BMSCs appeared to proceed down the endochondral pathway in vivo, with increased type X collagen expression and mineralisation of the engineered tissue. This occurred for both agarose encapsulation and SA.…”
Section: Discussionsupporting
confidence: 90%
“…While this is a major limitation associated with MSCs for articular cartilage tissue-engineering, this property has recently been leveraged for large bone defect regeneration (Harada et al, 2014;van der Stok et al, 2014). Previous studies have demonstrated that cartilaginous constructs engineered using BMSCs embedded in a hydrogel will proceed along an endochondral pathway in vivo (Dickhut et al, 2008;Vinardell et al, 2012). Indeed, previous work in our lab has shown that it is possible to engineer osteochondral constructs by spatially regulating endochondral ossification within bi-layered agarose cartilaginous grafts (Sheehy et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…They can be derived from natural materials which are either components of, or have macro-molecular properties similar to, native extra-cellular matrix [17], and a number of naturally derived hydrogels have been shown to support chondrogenesis of MSCs in vitro [18][19][20][21][22]. Previous studies have compared the chondrogenic capabilities of MSC-seeded hydrogels in vitro [23][24][25][26], and also the potential of chondrogenically primed MSC-seeded hydrogels to maintain a stable chondrogenic phenotype in vivo [27][28][29]. However, little is known about the capacity of different MSCseeded hydrogels to support the development of either phenotypically stable cartilage or endochondral bone in vitro and in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…There is also evidence to suggest that joint tissue derived multipotent stromal cells, such as those isolated from the infrapatellar fat pad (IFP) or synovium, may possess a superior chondrogenic potential to those derived from alternative sources (Sakaguchi et al, 2005;Vinardell et al, 2012b). In spite of this, the in vivo phenotypic stability of cartilaginous tissues engineered using such cells, irrespective of their origin, is by no means assured (De Bari et al, 2004;Pelttari et al, 2006;Hennig et al, 2007;Dickhut et al, 2008). Previous studies have shown that following in vivo subcutaneous implantation, IFP derived multipotent stromal cells (FPSCs) tend to undergo fibrous dedifferentiation or resorption, as evidenced by increased collagen type I and reduced sulphated glycosaminoglycan (sGAG) content, whereas bone marrow derived multipotent stromal cells (BMSCs) tend to follow an endochondral pathway, with increased mineralisation and vascularisation of the engineered tissue (Pelttari et al, 2006;Vinardell et al, 2012b).…”
Section: Introductionmentioning
confidence: 99%